What is GHRP-6?

GHRP-6 (Growth Hormone Releasing Peptide-6) is a synthetic peptide belonging to the group of growth hormone-releasing peptides (GHRPs). It stimulates the release of growth hormone (GH) from the anterior pituitary gland.

In medical research, GHRP-6 is being studied in the context of conditions associated with low growth hormone levels. Due to its effects on metabolic processes, muscle mass, and regeneration, this peptide is also discussed in the field of sports research and performance.

GHRP-6 acts as a ghrelin receptor agonist (GHS-R1a) in the pituitary and hypothalamus. This activation stimulates the secretion of growth hormone. Additionally, GHRP-6 shows a low affinity for somatostatin receptors, which can enhance its effectiveness in stimulating GH release.

Potential Benefits

GHRP-6 is associated with several possible effects in scientific and athletic contexts: support for muscle development, potential reduction of body fat, improved physical performance and endurance, support for an active metabolism, improved sleep quality, possible strengthening of immune function, support for muscle and connective tissue regeneration, and promotion of collagen production, beneficial for skin, hair, and nails.

Mechanism of Action

GHRP-6 stimulates growth hormone release primarily by activating the ghrelin receptor (Growth Hormone Secretagogue Receptor). This mechanism can influence protein synthesis and muscle growth, fat metabolism and energy production, tissue regeneration, as well as sleep and recovery processes. Increased GH release can also stimulate the production of IGF-1, which plays an important role in cell growth and tissue regeneration.

Dosage and Use

Dosage may vary depending on the objective and the protocol used. A frequently mentioned usage is 400 µg per day, divided into two doses: 200 µg in the morning and 200 µg in the evening, which is 8 units morning and evening with the dosing pen (1 unit = 25 µg). The injection is administered subcutaneously, generally in the abdominal area or the front of the thigh. After injection, wait approximately 10 seconds before removing the needle and regularly change the injection site. A typical cycle lasts approximately 4 to 6 months. One GHRP-6 pen (5 mg) contains 200 units and lasts approximately 13 to 15 days depending on the dosage.

Common Combinations

GHRP-6 is often combined with other peptides for potential synergistic effects, including CJC-1295 without DAC (which enhances GH release), Ipamorelin (selective GH secretagogue), IGF-1 LR3 (associated with cell growth and muscle development), and Sermorelin (GHRH analogue).

Possible Side Effects

As with many bioactive substances, side effects can occur. The most frequently reported are: pain or redness at the injection site, headaches, nausea, increased appetite, and possible weight gain. These effects are generally mild and transient.

Use in Sports

GHRP-6 is discussed in the context of improving athletic performance due to its influence on growth hormone production. For this reason, it is banned in professional sports by international anti-doping organizations.